Selection of chemotherapy by ex vivo assessment of tumor sensitivity to cytotoxic drugs: results of a clinical trial (Q44249053)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2002

edit

Language	Label	Description	Also known as
English	Selection of chemotherapy by ex vivo assessment of tumor sensitivity to cytotoxic drugs: results of a clinical trial	scientific article published in January 2002

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

title

Selection of chemotherapy by ex vivo assessment of tumor sensitivity to cytotoxic drugs: results of a clinical trial (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

main subject

cytotoxicity

0 references

chemotherapy

1 reference

based on heuristic

inferred from title

author

Bengt Glimelius

series ordinal

2

object named as

Bengt Glimelius

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

Peter Nygren

series ordinal

14

object named as

Peter Nygren

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

Rolf Larsson

series ordinal

8

object named as

Rolf Larsson

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

Anne von Heideman

series ordinal

7

object named as

Anne von Heideman

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

Bengt Tholander

series ordinal

9

object named as

Bengt Tholander

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

Hans Hagberg

series ordinal

6

object named as

Hans Hagberg

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

author name string

Ake Berglund

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

Jonas Bergh

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

Ola Brodin

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

Marie-Louise Fjällskog

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

Manuel de la Torre

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

Gunnar Aström

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

Kjell Oberg

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

Gunnar Parö

series ordinal

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

publication date

1 January 2002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

published in

Medical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

volume

19

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

page(s)

151-159

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

cites work

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between pharmacokinetic parameters in patients and cytotoxicity in vitro of standard and investigational anticancer drugs

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of tumor-specific cytotoxic drug activity in vitro using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of cremophor EL with bolus doxorubicin.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro drug sensitivity testing of tumor cells from patients with non-Hodgkin's lymphoma using the fluorometric microculture cytotoxicity assay

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro determination of cytotoxic drug response in ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of individual patient response to chemotherapy by the fluorometric microculture cytotoxicity assay (FMCA) using drug specific cut-off limits and a Bayesian model.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonogenic and nonclonogenic in vitro chemosensitivity assays

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is cancer chemotherapy?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laboratory prediction of clinical chemotherapeutic drug resistance: a working model exemplified by acute leukaemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxol: the first of the taxanes, an important new class of antitumor agents.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostics of malignant lymphomas with ultrasound guided 1.2 mm biopsy-gun

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12482125

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1385/MO:19:3:151

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

Dimensions Publication ID

1020054091

0 references

Fatcat ID

release_kiauc23mnzay5cigwk7siqtjfi

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/kiauc23mnzay5cigwk7siqtjfi

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

12482125

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12482125

retrieved

1 December 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44249053&oldid=2206524823"